In the 1950s, when mathematician and computer scientist Alan Turing posed the question, “Could a man-made device act and make decisions indistinguishable from those of humans?” he essentially launched the beginnings of a field of study that eventually became known as machine learning that produces artificial intelligence (AI). The implications for the infection prevention and control (IP&C) sector have yet to be fully actualized and comprehended, but experts say it is already revolutionizing healthcare delivery. To access the issue, CLICK HERE